Literature DB >> 8195315

Half-life of polyreactive antibodies.

G Sigounas1, N Harindranath, G Donadel, A L Notkins.   

Abstract

Monoclonal polyreactive antibodies bind to a variety of self and foreign antigens. In contrast, monoclonal monoreactive antibodies bind to a single or restricted number of known antigens. The rate at which polyreactive antibodies are removed from the circulation compared to monoreactive antibodies has not been determined. In the present experiments, human monoclonal polyreactive and monoreactive antibodies of different isotypes were injected intravenously into mice and the clearance from the circulation was determined. The half-life of polyreactive IgM, IgA, and IgG antibodies was 8.0, 8.2, and 9.8 hr, respectively, compared to 35.4, 26.6, and 280 hr for monoreactive IgM, IgA, and IgG antibodies, respectively. Examination of tissue sections from animals given intravenous antibody showed substantial deposition of polyreactive, but not monoreactive, antibodies in several organs, the liver being the principal site of deposition. It is concluded that polyreactive antibodies are cleared from the circulation substantially faster than monoreactive antibodies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8195315     DOI: 10.1007/bf01541346

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  38 in total

1.  Polyreactivity and antigen specificity of human xenoreactive monoclonal and serum natural antibodies.

Authors:  M A Turman; P Casali; A L Notkins; F H Bach; J L Platt
Journal:  Transplantation       Date:  1991-10       Impact factor: 4.939

Review 2.  Natural antibodies and the immune response.

Authors:  S V Boyden
Journal:  Adv Immunol       Date:  1966       Impact factor: 3.543

3.  Human monoclonal autoantibodies that react with multiple endocrine organs.

Authors:  J Satoh; B S Prabhakar; M V Haspel; F Ginsberg-Fellner; A L Notkins
Journal:  N Engl J Med       Date:  1983-07-28       Impact factor: 91.245

4.  Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset.

Authors:  P Casali; S E Burastero; M Nakamura; G Inghirami; A L Notkins
Journal:  Science       Date:  1987-04-03       Impact factor: 47.728

5.  The half-lives of IgG subclasses and specific antibodies in patients with primary immunodeficiency who are receiving intravenously administered immunoglobulin.

Authors:  S Mankarious; M Lee; S Fischer; K H Pyun; H D Ochs; V A Oxelius; R J Wedgwood
Journal:  J Lab Clin Med       Date:  1988-11

6.  Murine natural monoclonal autoantibodies: a study of their polyspecificities and their affinities.

Authors:  T Ternynck; S Avrameas
Journal:  Immunol Rev       Date:  1986-12       Impact factor: 12.988

7.  Effect of production method on the systemic clearance rate of a human monoclonal antibody in the rat.

Authors:  S S Gauny; J Andya; J Thomson; J D Young; J L Winkelhake
Journal:  Hum Antibodies Hybridomas       Date:  1991-01

8.  Polyreactive autoantibodies are nephritogenic in murine lupus nephritis.

Authors:  O G Pankewycz; P Migliorini; M P Madaio
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

9.  Clearance kinetics and fate of mouse IgA immune complexes prepared with monomeric or dimeric IgA.

Authors:  A Rifai; M Mannik
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

10.  Human monoclonal rheumatoid factor-like antibodies from CD5 (Leu-1)+ B cells are polyreactive.

Authors:  M Nakamura; S E Burastero; A L Notkins; P Casal
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

View more
  27 in total

1.  Polyreactive antigen-binding B (PAB-) cells are widely distributed and the PAB population consists of both B-1+ and B-1- phenotypes.

Authors:  Z-H Zhou; A L Notkins
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

Review 2.  Properties and function of polyreactive antibodies and polyreactive antigen-binding B cells.

Authors:  Zhao-Hua Zhou; Athanasios G Tzioufas; Abner Louis Notkins
Journal:  J Autoimmun       Date:  2007-09-20       Impact factor: 7.094

3.  Reduction of Nonspecificity Motifs in Synthetic Antibody Libraries.

Authors:  Ryan L Kelly; Doris Le; Jessie Zhao; K Dane Wittrup
Journal:  J Mol Biol       Date:  2017-11-26       Impact factor: 5.469

4.  Eliminating antibody polyreactivity through addition of N-linked glycosylation.

Authors:  Gwo-Yu Chuang; Baoshan Zhang; Krisha McKee; Sijy O'Dell; Young Do Kwon; Tongqing Zhou; Julie Blinn; Krissey Lloyd; Robert Parks; Tarra Von Holle; Sung-Youl Ko; Wing-Pui Kong; Amarendra Pegu; Keyun Wang; Kavitha Baruah; Max Crispin; John R Mascola; M Anthony Moody; Barton F Haynes; Ivelin S Georgiev; Peter D Kwong
Journal:  Protein Sci       Date:  2015-05-12       Impact factor: 6.725

5.  Biophysical properties of the clinical-stage antibody landscape.

Authors:  Tushar Jain; Tingwan Sun; Stéphanie Durand; Amy Hall; Nga Rewa Houston; Juergen H Nett; Beth Sharkey; Beata Bobrowicz; Isabelle Caffry; Yao Yu; Yuan Cao; Heather Lynaugh; Michael Brown; Hemanta Baruah; Laura T Gray; Eric M Krauland; Yingda Xu; Maximiliano Vásquez; K Dane Wittrup
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

6.  Establishing in vitro in vivo correlations to screen monoclonal antibodies for physicochemical properties related to favorable human pharmacokinetics.

Authors:  Lindsay B Avery; Jason Wade; Mengmeng Wang; Amy Tam; Amy King; Nicole Piche-Nicholas; Mania S Kavosi; Steve Penn; David Cirelli; Jeffrey C Kurz; Minlei Zhang; Orla Cunningham; Rhys Jones; Brian J Fennell; Barry McDonnell; Paul Sakorafas; James Apgar; William J Finlay; Laura Lin; Laird Bloom; Denise M O'Hara
Journal:  MAbs       Date:  2018-01-29       Impact factor: 5.857

7.  Polyreactive IgM antibodies in the circulation are masked by antigen binding.

Authors:  G Sigounas; N Kolaitis; E Monell-Torrens; A L Notkins
Journal:  J Clin Immunol       Date:  1994-11       Impact factor: 8.317

8.  Direct administration in the respiratory tract improves efficacy of broadly neutralizing anti-influenza virus monoclonal antibodies.

Authors:  Victor H Leyva-Grado; Gene S Tan; Paul E Leon; Mark Yondola; Peter Palese
Journal:  Antimicrob Agents Chemother       Date:  2015-05-04       Impact factor: 5.191

9.  Implications of continued response after autologous stem cell transplantation for multiple myeloma.

Authors:  Wilson I Gonsalves; Morie A Gertz; Angela Dispenzieri; Martha Q Lacy; Yi Lin; Preet P Singh; Vinay Gupta; Suzanne R Hayman; Francis K Buadi; David Dingli; Prashant Kapoor; Arleigh R McCurdy; Shaji K Kumar
Journal:  Blood       Date:  2013-07-17       Impact factor: 22.113

10.  Target-independent variable region mediated effects on antibody clearance can be FcRn independent.

Authors:  Ryan L Kelly; Yao Yu; Tingwan Sun; Isabelle Caffry; Heather Lynaugh; Michael Brown; Tushar Jain; Yingda Xu; K Dane Wittrup
Journal:  MAbs       Date:  2016-09-09       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.